Gold prices fell as U.S. 10-year Treasury yields rose, increasing the opportunity cost of holding non-yielding gold. Inflation data showed mixed signals with steady core CPI and slowing monthly PPI, while rising oil prices due to Middle East tensions added uncertainty. The gold market remains cautious, needing yields to drop before prices can recover strongly. Key levels to watch are support near $3,850 and resistance around $4,000, with upcoming CFTC positioning data and Fed meeting minutes expected to influence direction.
Gold’s weekly support near $3,850 and rising real yields to 2.86% provide context for market watchers. For readers following the US stock market, here is Pluang's market snapshot as of Nov 14, 2026 00:11 WIB: out of 150 priced US stocks tradable on Pluang, 74 rose and 75 fell today. Notable movers include CSCO at USD 96.16 with a 1-day change of -5.73% and Pluang order activity of 9% Sell / 91% Buy, AMAT at USD 362.29 down 4.90% with 56% Sell / 44% Buy, and HPE at USD 47.81 down 4.76% with 62% Sell / 38% Buy.
Susan R. Burns, Ph.D., President of the University of Mount Saint Vincent, has been awarded the 2027 Courageous Leadership Award for her visionary and bold leadership. Since 2021, she has led the university through significant transformation, includi...
Solo, a company specializing in privacy-preserving human verification, has integrated its SDK into JellyJelly, a social video app co-founded by Venmo's co-founder. This integration ensures that every JellyJelly account belongs to a real, unique perso...
The U.S. market for AI-enabled ophthalmic diagnostic devices is projected to grow from $72.5 million in 2026 to $267.2 million by 2033, expanding at a 20.5% CAGR. Growth is driven by rising diabetes-related eye diseases, FDA clearances for autonomous...
The global medical display monitors market, valued at $2.8 billion in 2025, is projected to grow to $4.0 billion by 2033 with a CAGR of 4.6%. Growth is fueled by rising adoption of digital imaging systems, demand for accurate diagnostics, and healthc...
Oppenheimer downgraded Enovix from Outperform to Perform as the company expands production in South Korea and shifts focus to drone and smart-eyewear customers. Enovix reported a 38% revenue increase to $11 million in Q3 but saw its adjusted loss wid...
